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Expanded Abstract 
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Objective 
Compared with standard medical therapy (SMT), 
noninvasive ventilation (NIV) does not reduce the need for 
reintubation in unselected patients who develop respiratory 
failure after extubation. The goal of this study was to assess 
whether early application of NIV, immediately after 
extubation, is effective in preventing postextubation 
respiratory failure in an at-risk population. 
Methods 
Design and setting: Multicenter randomized controlled 
study in three intensive care units (ICUs) 
Patients:  Ninety-seven consecutive patients with similar 
baseline characteristics requiring >48 hours of mechanical 
ventilation and considered at risk of developing 
postextubation respiratory failure (i.e., patients who had 
hypercapnia, congestive heart failure, ineffective cough and 
excessive tracheobronchial secretions, more than one 
failure of a weaning trial, more than one comorbid condition, 
and upper airway obstruction). 
Intervention: After a successful weaning trial, the patients 
were randomized to receive NIV for ≥8 hrs a day in the first 
48 hrs or SMT. Primary outcome was the need for 
reintubation according to standardized criteria. Secondary 
outcomes were ICU and hospital mortality as well as time 
spent in the ICU and in hospital. 
Measurements and main results: The trial was stopped 
early after interim analysis. Compared with the SMT group, 
the NIV group had a lower rate of reintubation (four of 48 
(8.3%) vs. 12 of 49 (24.5%); p = .027). The need for 
reintubation was associated with a higher risk of mortality (p 
< .01). The use of NIV resulted in a reduction of risk of ICU 
mortality (-10%, p < .01), mediated by the reduction in the 
need for reintubation. 
Conclusion 
NIV was more effective than SMT in preventing 
postextubation respiratory failure in a population considered 
at risk of developing this complication. 
Commentary 
Postextubation acute respiratory failure (ARF) is a common 
event, leading to reintubation in as many as 24% of patients 
[2,3] and increasing cost, length of stay, and mortality. NIV 
has been used to manage ARF in patients with chronic 
obstructive pulmonary disease (COPD) and acute 
cardiogenic pulmonary edema, leading others to suggest 
that it might be useful for patients with postextubation ARF. 
However, two recent randomized controlled studies failed to 
show a benefit of NIV in treating established postextubation 
ARF in heterogeneous patient populations [4,5]. In fact, the 
results from one study suggested that NIV is harmful [4]. 
An ancient proverb proposed that “an ounce of prevention is 
worth a pound of cure.” It is precisely this approach that 
Nava and coworkers [1] take in the current study. In this 
multicenter randomized control trial, the authors used NIV to 
prevent, rather than to treat, postextubation ARF, focusing 
their efforts on a select patient population at high risk of 
failure. The trial was stopped early at a planned interim 
analysis when it was found that NIV significantly lowered 
reintubation rates. The authors concluded that NIV may play 
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a role in the prevention of postextubation ARF in select 
high-risk patients groups. 
In the setting of postextubation ARF, the concept of 
prevention has significant face validity. Application of NIV 
prior to the onset of respiratory muscle fatigue or before 
there is significant atelectasis might avert a “vicious cycle” 
of increasing dyspnea, dysfunctional respiratory pattern and 
mechanics, and weakness culminating in overt respiratory 
failure.  
As is often the case, there are limitations to this study that 
deserve consideration. Foremost among these is that the 
study was stopped early. Though this decision occurred at a 
planned interim analysis, it resulted in a relatively small 
sample size that may have weakened the strength of the 
results and obscured a clear effect on mortality. By design, 
the investigators studied a select patient population. The 
study cohort included a high proportion of COPD patients, 
and NIV is known to be quite effective in this population. 
The results of this study, therefore, should not be extended 
to patient populations differing from those of the study.  
The application and titration of NIV can be a complicated 
endeavor. One cannot simply put a NIV mask on the 
patient, turn on the ventilator, and walk away. The authors 
have significant experience in the use of this technique, 
which accounts for the very high tolerance of NIV in the 
study and which might partially explain the observed 
difference in outcome. Although it is impossible to provide a 
single, uniform “prescription” for effectively applying NIV, 
recent clinical investigations suggest that close attention to 
patient-ventilator interaction can substantially improve 
tolerance of NIV. Elements of this interaction include the 
magnitude of the mask leak, the point at which the ventilator 
terminates inspiratory pressure application, and the rate at 
which the circuit is pressurized [6-9]. Interestingly, automatic 
adjustment of key parameters may some day be possible 
[10]. 
Recommendation 
These results, in context with a wealth of physiological data 
and clearly demonstrated utility in other settings, suggest 
that “prophylactic” postextubation NIV, properly applied, 
might prove to be a valuable adjunctive measure in select 
high-risk patients. Further study and confirmation are 
warranted. 
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